{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:13:54Z","timestamp":1793758434518,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gallic acid is a trihydroxybenzoic acid found in tea leaves and some plants. Here, we report the effect of gallic acid on cardiac dysfunction and fibrosis in a mouse model of pressure overload-induced heart failure and in primary rat cardiac fibroblasts, and compare the effects of gallic acid with those of drugs used in clinics. Gallic acid reduces cardiac hypertrophy, dysfunction, and fibrosis induced by transverse aortic constriction (TAC) stimuli <jats:italic>in vivo<\/jats:italic> and transforming growth factor \u03b21 (TGF-\u03b21) <jats:italic>in vitro<\/jats:italic>. It decreases left ventricular end-diastolic and end-systolic diameter, and recovers the reduced fractional shortening in TAC. In addition, it suppresses the expression of atrial natriuretic peptide, brain natriuretic peptide, skeletal \u03b1-actin, and \u03b2-myosin heavy chain. Administration of gallic acid decreases perivascular fibrosis, as determined by Trichrome II Blue staining, and reduces the expression of collagen type I and connective tissue growth factor. However, administration of losartan, carvedilol, and furosemide does not reduce cardiac dysfunction and fibrosis in TAC. Moreover, treatment with gallic acid inhibits fibrosis-related genes and deposition of collagen type I in TGF-\u03b21-treated cardiac fibroblasts. These results suggest that gallic acid is a therapeutic agent for cardiac dysfunction and fibrosis in chronic heart failure.<\/jats:p>","DOI":"10.1038\/s41598-018-27599-4","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T13:31:00Z","timestamp":1528810260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure"],"prefix":"10.1038","volume":"8","author":[{"given":"Li","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhee","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe Hao","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwi Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Jin","family":"Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"27599_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 135, e146\u2013e603 (2017).","journal-title":"Circulation"},{"key":"27599_CR2","doi-asserted-by":"crossref","unstructured":"deAlmeida, A. C., van Oort, R. J. & Wehrens, X. H. Transverse aortic constriction in mice. J Vis Exp (2010).","DOI":"10.3791\/1729"},{"key":"27599_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00418-008-0541-5","volume":"131","author":"Y Xia","year":"2009","unstructured":"Xia, Y. et al. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochemistry and cell biology 131, 471\u2013481 (2009).","journal-title":"Histochemistry and cell biology"},{"key":"27599_CR4","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI74783","volume":"124","author":"T Moore-Morris","year":"2014","unstructured":"Moore-Morris, T. et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. The Journal of clinical investigation 124, 2921\u20132934 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"27599_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers, J. G. et al. Cardiac Fibrosis: The Fibroblast Awakens. Circ Res 118, 1021\u20131040 (2016).","journal-title":"Circ Res"},{"key":"27599_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask, A. & Abraham, D. J. TGF-beta signaling and the fibrotic response. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 18, 816\u2013827 (2004).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"27599_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/ki.1992.81","volume":"41","author":"AB Roberts","year":"1992","unstructured":"Roberts, A. B., McCune, B. K. & Sporn, M. B. TGF-beta: regulation of extracellular matrix. Kidney international 41, 557\u2013559 (1992).","journal-title":"Kidney international"},{"key":"27599_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1523-1747.ep12363389","volume":"107","author":"K Frazier","year":"1996","unstructured":"Frazier, K. et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. The Journal of investigative dermatology 107, 404\u2013411 (1996).","journal-title":"The Journal of investigative dermatology"},{"key":"27599_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa020265","volume":"347","author":"D Levy","year":"2002","unstructured":"Levy, D. et al. Long-term trends in the incidence of and survival with heart failure. The New England journal of medicine 347, 1397\u20131402 (2002).","journal-title":"The New England journal of medicine"},{"key":"27599_CR10","first-page":"927160","volume":"2015","author":"L Luo","year":"2015","unstructured":"Luo, L. et al. Chinese Herbal Medicine in the Treatment of Chronic Heart Failure: Three-Stage Study Protocol for a Randomized Controlled Trial. Evidence-based complementary and alternative medicine: eCAM 2015, 927160 (2015).","journal-title":"Evidence-based complementary and alternative medicine: eCAM"},{"key":"27599_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1248\/bpb.b212022","volume":"36","author":"Y Katanasaka","year":"2013","unstructured":"Katanasaka, Y., Sunagawa, Y., Hasegawa, K. & Morimoto, T. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes. Biological & pharmaceutical bulletin 36, 13\u201317 (2013).","journal-title":"Biological & pharmaceutical bulletin"},{"key":"27599_CR12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.jnutbio.2013.01.008","volume":"24","author":"EM Seymour","year":"2013","unstructured":"Seymour, E. M., Bennink, M. R. & Bolling, S. F. Diet-relevant phytochemical intake affects the cardiac AhR and nrf2 transcriptome and reduces heart failure in hypertensive rats. The Journal of nutritional biochemistry 24, 1580\u20131586 (2013).","journal-title":"The Journal of nutritional biochemistry"},{"key":"27599_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.vph.2014.08.005","volume":"63","author":"HJ Kee","year":"2014","unstructured":"Kee, H. J. et al. Gallic acid inhibits vascular calcification through the blockade of BMP2-Smad1\/5\/8 signaling pathway. Vascul Pharmacol 63, 71\u201378 (2014).","journal-title":"Vascul Pharmacol"},{"key":"27599_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep34790","volume":"6","author":"Y Ryu","year":"2016","unstructured":"Ryu, Y. et al. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Sci Rep 6, 34790 (2016).","journal-title":"Sci Rep"},{"key":"27599_CR15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1097\/HJH.0000000000001327","volume":"35","author":"L Jin","year":"2017","unstructured":"Jin, L. et al. Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. J Hypertens 35, 1502\u20131512 (2017).","journal-title":"J Hypertens"},{"key":"27599_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15925-1","volume":"7","author":"L Jin","year":"2017","unstructured":"Jin, L. et al. Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats. Sci Rep 7, 15607 (2017).","journal-title":"Sci Rep"},{"key":"27599_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.vph.2017.10.007","volume":"99","author":"L Jin","year":"2017","unstructured":"Jin, L. et al. Gallic acid attenuates pulmonary fibrosis in a mouse model of transverse aortic contraction-induced heart failure. Vascul Pharmacol 99, 74\u201382 (2017).","journal-title":"Vascul Pharmacol"},{"key":"27599_CR18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0278-6915(01)00054-0","volume":"39","author":"N Niho","year":"2001","unstructured":"Niho, N. et al. Subchronic toxicity study of gallic acid by oral administration in F344 rats. Food Chem Toxicol 39, 1063\u20131070 (2001).","journal-title":"Food Chem Toxicol"},{"key":"27599_CR19","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.bbadis.2013.07.003","volume":"1832","author":"IA Sergeeva","year":"2013","unstructured":"Sergeeva, I. A. & Christoffels, V. M. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochim Biophys Acta 1832, 2403\u20132413 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"27599_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1582-4934.2008.00523.x","volume":"13","author":"RB Driesen","year":"2009","unstructured":"Driesen, R. B. et al. Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies. J Cell Mol Med 13, 896\u2013908 (2009).","journal-title":"J Cell Mol Med"},{"key":"27599_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3727\/105221611X12973615737505","volume":"15","author":"K Pandya","year":"2010","unstructured":"Pandya, K., Pulli, B., Bultman, S. & Smithies, O. Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression. Gene Expr 15, 51\u201359 (2010).","journal-title":"Gene Expr"},{"key":"27599_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1128\/MCB.00996-06","volume":"27","author":"S Goruppi","year":"2007","unstructured":"Goruppi, S., Patten, R. D., Force, T. & Kyriakis, J. M. Helix-loop-helix proteinp8, a transcriptional regulator required for cardiomyocyte hypertrophy and cardiac fibroblast matrix metalloprotease induction. Molecular and cellular biology 27, 993\u20131006 (2007).","journal-title":"Molecular and cellular biology"},{"key":"27599_CR23","doi-asserted-by":"publisher","first-page":"e001193","DOI":"10.1161\/JAHA.114.001193","volume":"3","author":"K Narayanan","year":"2014","unstructured":"Narayanan, K. et al. Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc 3, e001193 (2014).","journal-title":"J Am Heart Assoc"},{"key":"27599_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S0735-1097(00)00511-8","volume":"35","author":"MA Quinones","year":"2000","unstructured":"Quinones, M. A. et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 35, 1237\u20131244 (2000).","journal-title":"J Am Coll Cardiol"},{"key":"27599_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.biopha.2017.10.014","volume":"96","author":"F Ramezani-Aliakbari","year":"2017","unstructured":"Ramezani-Aliakbari, F. et al. Effects of gallic acid on hemodynamic parameters and infarct size after ischemia-reperfusion in isolated rat hearts with alloxan-induced diabetes. Biomed Pharmacother 96, 612\u2013618 (2017).","journal-title":"Biomed Pharmacother"},{"key":"27599_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cbi.2013.11.013","volume":"208","author":"S Umadevi","year":"2014","unstructured":"Umadevi, S., Gopi, V. & Elangovan, V. Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats. Chem Biol Interact 208, 28\u201336 (2014).","journal-title":"Chem Biol Interact"},{"key":"27599_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1515\/jbcpp-2016-0194","volume":"29","author":"TO Omobowale","year":"2018","unstructured":"Omobowale, T. O. et al. Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats. J Basic Clin Physiol Pharmacol 29, 19\u201327 (2018).","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"27599_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1515\/intox-2016-0008","volume":"9","author":"TO Ajibade","year":"2016","unstructured":"Ajibade, T. O. et al. Mitigation of diazinon-induced cardiovascular and renal dysfunction by gallic acid. Interdiscip Toxicol 9, 66\u201377 (2016).","journal-title":"Interdiscip Toxicol"},{"key":"27599_CR29","doi-asserted-by":"crossref","unstructured":"Ogunsanwo, O. R. et al. Biochemical and electrocardiographic studies on the beneficial effects of gallic acid in cyclophosphamide-induced cardiorenal dysfunction. J Complement Integr Med 14 (2017).","DOI":"10.1515\/jcim-2016-0161"},{"key":"27599_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1139\/cjpp-2015-0446","volume":"94","author":"HM El-Hussainy el","year":"2016","unstructured":"El-Hussainy el, H. M., Hussein, A. M., Abdel-Aziz, A. & El-Mehasseb, I. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can J Physiol Pharmacol 94, 868\u2013878 (2016).","journal-title":"Can J Physiol Pharmacol"},{"key":"27599_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1139\/cjpp-2012-0279","volume":"91","author":"V Vijaya Padma","year":"2013","unstructured":"Vijaya Padma, V., Poornima, P., Prakash, C. & Bhavani, R. Oral treatment with gallic acid and quercetin alleviates lindane-induced cardiotoxicity in rats. Can J Physiol Pharmacol 91, 134\u2013140 (2013).","journal-title":"Can J Physiol Pharmacol"},{"key":"27599_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2009.05.003","volume":"615","author":"P Stanely Mainzen Prince","year":"2009","unstructured":"Stanely Mainzen Prince, P., Priscilla, H. & Devika, P. T. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. Eur J Pharmacol 615, 139\u2013143 (2009).","journal-title":"Eur J Pharmacol"},{"key":"27599_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yjmcc.2016.05.012","volume":"97","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice. J Mol Cell Cardiol 97, 180\u2013190 (2016).","journal-title":"J Mol Cell Cardiol"},{"key":"27599_CR34","doi-asserted-by":"publisher","first-page":"205031211770005","DOI":"10.1177\/2050312117700057","volume":"5","author":"C Hampton","year":"2017","unstructured":"Hampton, C. et al. Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model. SAGE Open Med 5, 2050312117700057 (2017).","journal-title":"SAGE Open Med"},{"key":"27599_CR35","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.2147\/DDDT.S144807","volume":"11","author":"WW Zhang","year":"2017","unstructured":"Zhang, W. W. et al. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor. Drug Des Devel Ther 11, 3019\u20133033 (2017).","journal-title":"Drug Des Devel Ther"},{"key":"27599_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nutres.2015.10.001","volume":"36","author":"DW Huang","year":"2016","unstructured":"Huang, D. W. et al. Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet. Nutr Res 36, 150\u2013160 (2016).","journal-title":"Nutr Res"},{"key":"27599_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/0974-8490.89743","volume":"3","author":"SS Patel","year":"2011","unstructured":"Patel, S. S. & Goyal, R. K. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy Res 3, 239\u2013245 (2011).","journal-title":"Pharmacognosy Res"},{"key":"27599_CR38","doi-asserted-by":"publisher","first-page":"101042831769912","DOI":"10.1177\/1010428317699127","volume":"39","author":"HA Aglan","year":"2017","unstructured":"Aglan, H. A., Ahmed, H. H., El-Toumy, S. A. & Mahmoud, N. S. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. Tumour Biol 39, 1010428317699127 (2017).","journal-title":"Tumour Biol"},{"key":"27599_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.toxrep.2015.03.001","volume":"2","author":"S Kamatham","year":"2015","unstructured":"Kamatham, S., Kumar, N. & Gudipalli, P. Isolation and characterization of gallic acid and methyl gallate from the seed coats of Givotia rottleriformis Griff. and their anti-proliferative effect on human epidermoid carcinoma A431 cells. Toxicol Rep 2, 520\u2013529 (2015).","journal-title":"Toxicol Rep"},{"key":"27599_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.etap.2013.02.011","volume":"35","author":"S Verma","year":"2013","unstructured":"Verma, S., Singh, A. & Mishra, A. Gallic acid: molecular rival of cancer. Environ Toxicol Pharmacol 35, 473\u2013485 (2013).","journal-title":"Environ Toxicol Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27599-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:24:20Z","timestamp":1671603860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27599-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["27599"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-27599-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"26 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9302"}}